Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/1996
12/19/1996CA2222586A1 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/19/1996CA2222551A1 Tumor associated epitopes
12/19/1996CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996CA2222183A1 Stable reagents for the preparation of radiopharmaceuticals
12/19/1996CA2221780A1 Anti-fungal d-amino acid histatin-based peptides
12/19/1996CA2221146A1 Structurally determined metallo-constructs and applications
12/19/1996CA2220714A1 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
12/18/1996EP0748379A1 Modulators of anchoring protein function
12/18/1996EP0748336A1 Immunosuppressive compounds and method of preparing same
12/18/1996EP0748334A1 Insect neuropeptides
12/18/1996EP0748226A1 Block copolymers
12/18/1996EP0618802A4 Synthetic compounds and compositions with enhanced cell binding.
12/18/1996EP0554284B1 Peptide-based inhibitors of hiv replication
12/18/1996CN1138350A CNTF Family antagonists
12/18/1996CN1138335A Compounds with growth hormone releasing properties
12/18/1996CN1138334A Compounds with growth hormone releasing properties
12/17/1996US5585475 Does not exhibit strict alpha-helical conformations
12/17/1996US5585356 Matrix metalloproteinase peptides: role in diagnosis and therapy
12/17/1996CA2006684C Monoclonal antibody against protein c
12/12/1996WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
12/12/1996WO1996039426A1 Hypoxia inducible factor-1 and method of use
12/12/1996WO1996039425A2 Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity
12/12/1996WO1996039409A1 Nitrosylated and nitrated superoxide oxidants and reductants
12/12/1996WO1996039161A1 Multi-tyrosinated somatostatin analogs
12/12/1996WO1996030055A3 Radiolabeled peptides for diagnosis and therapy
12/12/1996CA2222962A1 Multi-tyrosinated somatostatin analogs
12/11/1996EP0747351A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/11/1996EP0746605A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity
12/11/1996EP0746568A1 Method for the preparation of glycopeptidic antibiotic precursors by intramolecular cyclisation and formation of a biaryl ether bridge and novel compounds so obtained
12/11/1996EP0746565A1 Novel bombesin-related peptides
12/11/1996EP0746340A1 Peptide-chelator conjugates
12/11/1996EP0437556B1 Substitution analogues of magainin peptides
12/10/1996US5583111 Water soluble leech extract
12/10/1996US5582997 Having antimicrobial, hemolytic and catalytic activity
12/10/1996US5582995 Methods of screening for compounds which inhibit the direct binding of Ras to Raf
12/05/1996WO1996038473A2 Antimicrobial cationic peptides
12/05/1996WO1996038472A1 Cocoa flavour precursor peptides, dna encoding them, processes for producing the peptides, and their use for generating cocoa flavour
12/05/1996WO1996038185A1 Sequestered imaging agents
12/05/1996WO1996038164A1 Serum immunoregulatory polypeptides and uses therefor
12/05/1996WO1996038163A1 Compositions containing an antibiotic and a peptide potentiating this antibiotic
12/05/1996WO1996034884A3 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use
12/05/1996CA2222863A1 Serum immunoregulatory polypeptides and uses therefor
12/05/1996CA2222599A1 Antimicrobial cationic peptides
12/05/1996CA2218877A1 Sequestered imaging agents
12/04/1996EP0745093A1 New oligopeptides with affinity to opioid receptors
12/04/1996EP0745092A1 Peptide inhibitors of urokinase receptor activity
12/04/1996EP0745091A1 Use of angiotensin ii analogs in tissue repair
12/04/1996EP0744955A1 Cyclic heptapeptide anti-inflammatory agent
12/03/1996US5580957 Gonadotropin inhibitor
12/03/1996US5580747 Quantitative analysis
12/03/1996US5580739 Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
12/03/1996US5580561 Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide
12/03/1996CA2036997C Leu3a binding peptides
11/1996
11/28/1996WO1996037512A1 Cyclic peptide antifungal agents
11/28/1996WO1996037511A1 Cyclic peptides antifungal agents
11/28/1996WO1996037510A1 Cyclic peptide antifungal agents
11/28/1996WO1996037509A1 Cyclic peptide antifungal agents
11/28/1996WO1996037508A1 Protegrins
11/28/1996WO1996037239A1 Peptide radiopharmaceutical applications
11/28/1996WO1996037212A1 POLYPEPTIDE COMPOUNDS THAT FORM β SHEETS
11/28/1996CA2222475A1 Protegrins
11/28/1996CA2220944A1 Cyclic peptide antifungal agents
11/28/1996CA2220728A1 Cyclic peptide antifungal agents
11/28/1996CA2220688A1 Cyclic peptide antifungal agents
11/28/1996CA2219492A1 Peptide radiopharmaceutical applications
11/27/1996EP0744407A2 Cyclic peptide antifungal agents
11/27/1996EP0744406A2 Cyclic peptide antifungal agents
11/27/1996EP0744405A2 Cyclic peptide antifungal agents
11/27/1996EP0744404A2 Cyclic peptide antifungal agents
11/27/1996EP0744027A1 Hydrophilic signal oligopeptides and methods of therapeutic use
11/27/1996EP0743955A1 Nerve growth factor structural analogs and their uses
11/27/1996CN1136779A Long-acting injection suspensions and process for their preparation
11/27/1996CN1136778A Sperm antigen corresponding to sperm zone binding protein autoantigenic epitope
11/26/1996US5578715 Methods, kits, and probes for diagnosing HIV-2
11/26/1996US5578707 Soluble interferon-gamma receptor fragment
11/26/1996US5578573 Viral integrase inhibiting peptides
11/26/1996US5578569 Method of increasing bone growth
11/26/1996US5578479 Alpha-amylase from hyperthermophilic archaebacterium
11/26/1996CA2033448C Antiherpes compositions and method of use
11/21/1996WO1996036722A2 Embedded expression of heterologous proteins
11/21/1996WO1996036645A1 Synthetic peptide analogs of cross-linked n-telopeptides of type i collagen
11/20/1996EP0742902A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
11/20/1996EP0742794A1 Interleukin-6 (il-6) antagonists
11/19/1996US5576298 Peptides from pseudomonas syringae possessing broad-spectrum antibiotic activity
11/19/1996US5576296 Galanin antagonist
11/19/1996US5576290 Compositions and methods for the diagnosis and treatment of psychogenic erectile dysfunction
11/19/1996US5576189 Antibody to type-I collagen amino-terminal telopeptide
11/19/1996CA1338728C Cyclosporins and their use a pharmaceuticals
11/14/1996WO1996015148A3 Low molecular weight peptidomimetic growth hormone secretagogues
11/13/1996EP0741869A1 Specific binding substances for antibodies and their use for immunoassays or vaccines
11/13/1996EP0741744A1 Immunogens against gonadotropin releasing hormone
11/13/1996EP0741743A1 Cyclic neurokinin a antagonists
11/12/1996US5574132 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
11/12/1996US5573943 Cloning and expression of a rhoptry associated protein of P. falciparum
11/12/1996US5573936 Fungicide
11/12/1996US5573767 Lutenizing hormone-releasing hormone
11/07/1996WO1996034884A2 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use
11/07/1996WO1996034881A1 Peptide compositions with growth factor-like activity
11/07/1996WO1996034618A1 Tissue adhesive using synthetic cross-linking
11/07/1996WO1996034617A1 COMPOUNDS THAT BIND TO p185 AND METHODS OF USING THE SAME
1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 423